KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Notes Payables (2018 - 2025)

Biogen has reported Notes Payables over the past 13 years, most recently at $1.7 billion for Q1 2025.

  • Quarterly results put Notes Payables at $1.7 billion for Q1 2025, up 599.64% from a year ago — trailing twelve months through Mar 2025 was $1.7 billion (up 599.64% YoY), and the annual figure for FY2024 was $1.7 billion, down 74.8%.
  • Notes Payables for Q1 2025 was $1.7 billion at Biogen, roughly flat from $1.7 billion in the prior quarter.
  • Over the last five years, Notes Payables for BIIB hit a ceiling of $7.3 billion in Q2 2022 and a floor of $250.0 million in Q1 2024.
  • Median Notes Payables over the past 5 years was $6.3 billion (2023), compared with a mean of $4.6 billion.
  • Biggest five-year swings in Notes Payables: tumbled 74.8% in 2024 and later soared 599.64% in 2025.
  • Biogen's Notes Payables stood at $7.3 billion in 2021, then grew by 0.06% to $7.3 billion in 2022, then dropped by 4.66% to $6.9 billion in 2023, then tumbled by 74.8% to $1.7 billion in 2024, then rose by 0.03% to $1.7 billion in 2025.
  • The last three reported values for Notes Payables were $1.7 billion (Q1 2025), $1.7 billion (Q4 2024), and $6.3 billion (Q3 2024) per Business Quant data.